Business Segments Cardiol Therapeutics Inc.
Stocks
CRDL
CA14161Y2006
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 CAD | -.--% |
|
-1.65% | +13.74% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||||
Pharmaceuticals | 78.76K | - | - | - | - | ||||
Total Assets | 87.88M | 62.03M | 36.7M | 31.86M | 23.62M | ||||
Interest Expense | - | - | - | - | - | ||||
CAPEX | -12.92K | -74.71K | -64.31K | -21.29K | -24.48K | ||||
EBT | -31.64M | -30.93M | -28.13M | -36.68M | -33.82M | ||||
D&A | 220K | 220K | 248K | 226K | 102K | ||||
Net Income | -31.64M | -30.93M | -28.13M | -36.68M | -33.82M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Canada | 78.76K | - | - | - | - | ||||
Total Assets | 87.88M | 62.03M | 36.7M | 31.86M | 23.62M | ||||
Interest Expense | - | - | - | - | - | ||||
D&A | 220K | 220K | 248K | 226K | 102K | ||||
CAPEX | -12.92K | -74.71K | -64.31K | -21.29K | -24.48K | ||||
Net Income | -31.64M | -30.93M | -28.13M | -36.68M | -33.82M | ||||
EBT | -31.64M | -30.93M | -28.13M | -36.68M | -33.82M |
- Stock Market
- Stocks
- CRDL Stock
- Financials Cardiol Therapeutics Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
